C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

Immune molecules, which have been found to be important in tumor microenvironment, seem prospective in tumor therapy, but they are still not effective enough to use in clinical practice. C-C motif chemokine 22 (CCL22) exists in various malignancies and correlates with migration of regulatory T cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Wu, Songyang, He, Hongyong, Liu, Hao, Cao, Yifan, Li, Rochen, Zhang, Heng, Li, He, Shen, Zhenbin, Qin, Jing, Xu, Jiejie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980413/
https://ncbi.nlm.nih.gov/pubmed/29872564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1433517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados